Antibiotic prophylaxis and non-group B streptococcal neonatal sepsis

Obstetrics and Gynecology

Volumn 105, Issue 3, 2005, Pages 581-586

  Sutkin, Gary ^a   Krohn, Marijane A ^b   Heine, R Phillips ^b   Sweet, Richard L ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; DRUG USE; ESCHERICHIA COLI; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

EID: 13944250301     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000153492.30757.2f     Document Type: Article

References (35)

1. Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol 1999;20:242-6.
2. López Sastre JB, Cotallo Goto GD, Fernândez Colomer BF. Neonatal sepsis of vertical transmission: an epidemiological study from the Grupo de Hospitales Castrillo. J Perinat Med 2000;28:309-15,
3. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000;105:21-6.
4. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
5. Prevention of early-onset group B streptococcal disease in newborns. AGOG Committee Opinion No. 279. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:1405-12.
6. Prevention of perinatal group B streptococcal disease: a public health perspective [published erratum appears in MMWR Morb Mortal Wkly Rep 1996;45:679]. MMWR Recomm Rep 1996;45 RR-7:1-24.
7. Prevention of perinatal group B streptococcal disease: a public health perspective [published erratum appears in MMWR Morb Mortal Wkly Rep 1996;45:679]. MMWR Recomm Rep 1996;45 RR-7:1-24.
8. Brozanski BS, Jones JG, Krohn MA, Sweet RL. Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis. Obstet Gynecol 2000;95:496-501.
9. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3.
10. Isaacs D, Royle JR. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Pediatr Infect Dis J 1999;18:524-8.
11. Main EK, Slagle T. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. Am J Obstet Gynecol 2000;182:1344-54.
12. Lin FYC, Brenner RA, Johnson YR, Azimi PA, Philips JB, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204-10.
13. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8.
14. Chen KT, Tuomala RE, Cohen AP, Eichenwald EC, Lieberman E. No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms. Am J Obstet Gynecol 2001;185:854-8.
15. Wendel GD, Leveno KJ, Sanchez PJ, Jackson GL, McIntire DD, Siegel JD. Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol. Am J Obstet Gynecol 2002;186:618-26.
16. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing-early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7.
17. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
18. Velaphi S, Siegel JD, Wendel GD, Cushion N, Eid WM, Sanchez PJ. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003;111:541-7.
19. Bax R, Mullan N, Verhoef J. The millennium bugs: the need for and development of new antibacterials. Int J Antimicrob Agents 2000;16:51-9.
20. Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol 2002;187:495-500.
21. Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53.
22. McDuffie RS Jr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487-9.
23. Mercer BM, Carr TL, Beazley DD, Grouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999;181:816-21.
24. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN, Perry KG. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 1999;180:1345-8.
25. Edwards RK, Locksmith GJ, Duff P. Expanded-spectrum antibiotics with preterm premature rupture of membranes. Obstet Gynecol 2000;96:60-4.
26. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-83.
27. Sinha A, Yokoe D, Platt R. Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus. J Pediatr 2003;142:492-7.
28. Factor SH, Levine OS, Nassar A, Potter J, Fajardo A, O'Sullivan MJ, et al. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol 1998;179:1568-71.
29. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110:690-5.
30. Joseph TA, Pyati SP, Jacobs N. Neonatal early-onset Escherichia coli disease. Arch Pediatr Adolesc Med 1998;152:35-40.
31. Sanghvi KP, Tudehope D. Neonatal bacterial sepsis in a neonatal intensive care unit: a 5-year analysis. J Paediatr Child Health 1996;32:333-8.
32. Kaushik SL, Parmar VR, Grover N, Grover PS, Kaushik R. Neonatal sepsis in hospital born babies. J Commun Dis 1998;30:147-52.
33. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387.
34. Lopez Sastre JB, Coto Cotallo D, Fernandez Colomer B, Grupo de Hospitales Castrillo. Neonatal sepsis of nosocomial origin: an epidemiological study from the Grupo de Hospitales Castrillo. J Perinat Med 2002;30:149-57.
35. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3:201-13.